Inhalers and insulin dominate new export ban products
Asthma medications and insulin products make up the vast majority of the medicines newly added to the Department of Health And Social Careâ€™s parallel export ban list, which is designed to help the UK cope with shortages. Â
On Tuesday 52 medicines were added to the list of products that cannot be exported because they are needed for UK patients, bringing the total number to 168 â€“ a record high.
Among the new medications on the list are 23 insulin products and 22 asthma medications, including a number of salbutamol and/or beclometasone preparations.
There have been numerous reports of pharmacies struggling to source enough inhalers to meet patient demand since the Covid-19 pandemic hit Britain, in part because of some prescriptions being issued for a longer than normal period.
A Covid-19 survey of 449 pharmacists carried out last weekend by Pharmacy Magazine and Independent Community Pharmacist found that Clenil was the medicine that was second-worst affected by shortages after paracetamol, with 60 per cent of respondents saying they had struggled to source it in the previous two weeks.
Meanwhile, 40 per cent said they had struggled to source other inhalers.
Codeine, doxycycline and diamorphine were some of the other medicines added to the ban list this week.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Care home pharmacists deployed in 'army of experts'
NHS England is to recruit 200 'clinical pharmacists' and pharmacy technicians to an “army of experts” tasked with reducing unnecessary medication.
1 Min Article
Pain conversations - making effective recommendations
Explore our detailed case studies to help understand how to advise customers on different causes of pain.
19 Min Module
This module will help the pharmacy team to understand erectile dysfunction and its causes, and supply Viagra Connect to male customers affected by it, where appropriate
15 Min Module